首页 正文

Henoch-Schönlein purpura following mRNA COVID-19 vaccination: a case report

{{output}}
The coronavirus disease 2019 (COVID-19) vaccine was developed to provide immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in 2019. The vaccine has proven to be effective in reducing severity and mortality ... ...